American Board of Pathology (ABPath) · Neuropathology Exam Blueprint, explicitly marked Updated for 2026, verified on 2026-10-09. Supplemented by the Neuropathology Content Specifications currently linked as Final Version; its filename contains final10092025, but the PDF states no explicit effective date. General management/informatics specifications carry 03/2026. The workbook label maps to ABPath's Neuropathology Subspecialty Certification Exam; the assigned slug is preserved.

This original 20-question sample covers selected topics across the outline. It does not reproduce official exam questions or cover every tested topic.

• Neuropathology — American Board of Pathology
• ABPath Virtual Microscopy Samples
• Neuropathology Exam Blueprint — Updated for 2026
• Content Specifications for Examinations
• Neuropathology Content Specifications
• Management and Informatics Content Specifications — 03/2026
• Ubiquitin in normal, reactive and neoplastic human astrocytes
• Late oligodendrocyte progenitors coincide with the developmental window of vulnerability for human perinatal white matter injury
• The clinicopathologic spectrum of focal cortical dysplasias — ILAE consensus classification, 2011
• The ILAE consensus classification of focal cortical dysplasia: An update — 2022
• Development, appraisal, validation and implementation of a consensus protocol for the assessment of cerebral amyloid angiopathy
• Early detection of axonal injury after human head trauma using immunocytochemistry for β-amyloid precursor protein
• Progressive Multifocal Leukoencephalopathy/JC Virus — NIH Adult and Adolescent OI Guidelines
• CDC Public Health Image Library — Cryptococcus, mucicarmine stain
• Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis
• Wernicke-Korsakoff Syndrome — NIAAA
• NIA-AA guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach
• Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies
• Clinical Overview of Creutzfeldt-Jakob Disease — CDC
• Oligodendroglioma and Other IDH-Mutated Tumors: Diagnosis and Treatment — NCI
• cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas
• Von Hippel-Lindau Disease (PDQ) — Health Professional Version
• Clinical and Molecular Characteristics of Gonadotroph Pituitary Tumors According to the WHO Classification
• Overview of the 2022 WHO Classification of Pituitary Tumors
• Clinical assessment determines the diagnosis of inclusion body myositis independently of pathological features
• Evaluation and construction of diagnostic criteria for inclusion body myositis
• DNA duplication associated with Charcot-Marie-Tooth disease type 1A
• Charcot-Marie-Tooth polyneuropathy: duplication, gene dosage, and genetic heterogeneity
• A frame shift mutation in the PMP22 gene in hereditary neuropathy with liability to pressure palsies
• Retinoblastoma Treatment (PDQ) — Health Professional Version
• Validating Whole Slide Imaging Systems for Diagnostic Purposes in Pathology — Guideline Update Methodology Supplement
• Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline - PMC
• ajnd1402006.pdf
• wernicke-korsakoff.pdf
• How to Send a Muscle Biopsy | University of Iowa Diagnostic Laboratories (UIDL) - Carver College of Medicine | The University of Iowa
• Evidence of aquaporin involvement in human central pontine myelinolysis - PMC
• Molecular-diagnostic-tools-for-the-world-health-organization-who-2021-classification-of-gliomas-glioneuronal-and-neur.pdf
• International-consensus-classification-hippocampal-sclerosisBlumcke-2013-Epilepsia.pdf
• view.php
• Size of Mamillary Bodies in Health and Disease: Useful Measurements in Neuroradiological Diagnosis of Wernicke's Encephalopathy - PMC